Medicare Enrolled

Dr. Naheed Bashir, M.D.

Pain Medicine · Belleville, IL
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
1 BRONZE POINTE, Belleville, IL 62226
6182337055
In practice since 2007 (19 years)
NPI: 1245355916 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Bashir from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Bashir? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Bashir

Dr. Naheed Bashir is a pain medicine specialist in Belleville, IL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Bashir performed 3,075 Medicare services across 1,301 unique beneficiaries.

Between the years covered by Open Payments, Dr. Bashir received a total of $4,331 from 31 pharmaceutical and/or device companies across 287 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pain medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Bashir is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 20% volume in IL $4,331 industry payments

Medicare Practice Summary

Medicare Utilization ↗
3,075
Medicare services
Top 20% in IL for pain medicine
1,301
Unique beneficiaries
$64
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~162 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
1,497 $64 $187
Drug test with direct observation
A drug screening test performed under direct observation to ensure the sample is provided correctly. This method is used to verify the integrity of the specimen collection process.
455 $12 $140
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
224 $94 $245
Injection, methylprednisolone acetate, 40 mg 188 $6 $25
Methylprednisolone acetate injection, 80 mg
An injection of 80 mg of methylprednisolone acetate, a corticosteroid medication.
123 $9 $30
Telephone medical discussion, 11-20 minutes
A phone conversation with a physician lasting between 11 and 20 minutes.
71 $68 $146
Spine facet joint injection with imaging guidance, single level
An injection is administered into a single facet joint of the lower or sacral spine while using imaging guidance to ensure accurate placement.
59 $187 $690
Facet joint injection, second level, with imaging guidance
An injection into a lower or sacral spine facet joint using imaging guidance for the second level treated.
59 $84 $360
Injection of anesthetic or steroid into sacroiliac joint with imaging guidance
This procedure involves injecting an anesthetic or steroid medication into the joint connecting the lower spine and hip bone. Imaging guidance is used to ensure accurate placement of the injection.
53 $124 $700
Joint injection, major joint
Removal of fluid from a large joint and/or injection of medication into the joint space.
51 $55 $215
Injection into lower spine canal with imaging guidance
A procedure where a substance is injected into the lower part of the spinal canal. The injection is performed using imaging guidance to ensure accurate placement.
44 $188 $1,400
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
41 $39 $86
Facet joint nerve destruction, single joint
A procedure to destroy nerves in a single lower or sacral spinal facet joint using imaging guidance to target pain signals.
36 $332 $1,565
Facet joint nerve destruction, additional joint
This procedure uses imaging guidance to destroy nerves in an additional lower or sacral spinal facet joint.
35 $181 $800
Spine facet joint injection with imaging guidance, single level
An injection is administered into a single facet joint of the upper or middle spine while using imaging guidance to ensure accurate placement.
32 $141 $1,300
Facet joint injection, second level, with imaging
An injection into a second spinal facet joint in the upper or middle spine, guided by imaging to ensure accurate placement.
32 $76 $1,200
Fluoroscopic guidance for needle placement
Use of real-time X-ray imaging to guide the precise placement of a needle during a medical procedure.
24 $87 $325
Telephone medical discussion, 5-10 minutes
A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters.
20 $43 $98
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
16 $120 $327
Trigger point injection, 3 or more muscles
Injection of medication into three or more specific muscle trigger points to relieve pain.
15 $47 $230
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$4,331
Total received (2018-2024)
Avg $619/year across 7 years
Top 32% in IL for pain medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
31
Companies
287
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,261 (98.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$70 (1.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$513
2023
$595
2022
$470
2021
$849
2020
$552
2019
$494
2018
$859

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$276
Valinor Pharma, LLC
$147
Collegium Pharmaceutical, Inc.
$39
VERTEX PHARMACEUTICALS INCORPORATED
$20
Abbott Laboratories
$18
PFIZER INC.
$14
Top 3 companies account for 90.0% of 2024 payments
All-time payments by company (2018-2024) ›
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$1,689
Collegium Pharmaceutical, Inc.
$546
Daiichi Sankyo Inc.
$316
Abbott Laboratories
$193
BioDelivery Sciences International, Inc.
$189
Valinor Pharma, LLC
$182
Amgen Inc.
$141
PFIZER INC.
$112
RedHill Biopharma Inc.
$99
Novartis Pharmaceuticals Corporation
$96
Biohaven Pharmaceutical Holding Company Ltd.
$74
Hikma Pharmaceuticals USA
$70
AstraZeneca Pharmaceuticals LP
$70
Biohaven Pharmaceuticals, Inc.
$66
Lilly USA, LLC
$61
BIODELIVERY SCIENCES INTERNATIONAL, INC.
$51
AbbVie Inc.
$47
GRT US Holding, Inc.
$45
Pernix Therapeutics Holdings, Inc.
$43
Takeda Pharmaceuticals U.S.A., Inc.
$39
Shionogi Inc
$29
Scilex Pharmaceuticals Inc.
$22
Kaleo, Inc.
$22
VERTEX PHARMACEUTICALS INCORPORATED
$20
Baudax Bio Inc.
$19
Virtus Pharmaceuticals LLC
$18
Sentynl Therapeutics, Inc.
$17
DePuy Synthes Sales Inc.
$17
SI-BONE, INC.
$14
Purdue Pharma L.P.
$14
ABBVIE INC.
$12
Top 3 companies account for 58.9% of all-time payments
Associated products mentioned in payments ›
AIMOVIG · ANJESO · Aimovig · Amitiza · BELBUCA · BUNAVAIL · BUNAVAIL 2.1 mg 30-count box · Belbuca · EMGALITY · EVZIO · Emboshield NAV6 system · INJECTAFER · Kloxxado · LEVORPHANOL TARTRATE · LYRICA · Levorphanol Tartrate · MONOVISC · MOVANTIK · Morphabond ER · Movantik · NURTEC ODT · Nucynta · PROCLAIM · Proclaim Family of SCS IPGs · QULIPTA · Qutenza · RELISTOR · RELISTOR ORAL · SYMPROIC · Symproic · UBRELVY · XTAMPZA · XTAMPZAER · Xtampza ER · ZOHYDRO ER · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a pain medicine specialist in Belleville?
Compare pain medicines in the Belleville area by procedure volume, costs, and industry payment transparency.
Browse pain medicines nearby

Geographic Context

Pain medicines within 10 mi
3
Per 100K population
1.2
County median income
$70,178
Nearest hospital
MEMORIAL HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Bashir is a clinical cardiology specialist, with above-average Medicare volume (top 20% in IL), with low-engagement industry engagement, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Bashir experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Bashir performed 1,497 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Bashir receive payments from pharmaceutical companies?
Yes. Dr. Bashir received a total of $4,331 from 31 companies across 287 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Bashir's costs compare to other pain medicines in Belleville?
Dr. Bashir's average Medicare payment per service is $64. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Bashir) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →